Logo image of DHAI

DIH HOLDINGS US INC (DHAI) Stock Fundamental Analysis

NASDAQ:DHAI - Nasdaq - US23290B1061 - Common Stock - Currency: USD

0.66  -0.03 (-4.35%)

Fundamental Rating

1

Overall DHAI gets a fundamental rating of 1 out of 10. We evaluated DHAI against 189 industry peers in the Health Care Equipment & Supplies industry. DHAI may be in some trouble as it scores bad on both profitability and health. DHAI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DHAI had positive earnings in the past year.
DHAI had a negative operating cash flow in the past year.
DHAI Yearly Net Income VS EBIT VS OCF VS FCFDHAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 2M 4M 6M

1.2 Ratios

The Return On Assets of DHAI (1.45%) is better than 72.34% of its industry peers.
The Return On Equity of DHAI (1.80%) is better than 72.87% of its industry peers.
Industry RankSector Rank
ROA 1.45%
ROE 1.8%
ROIC N/A
ROA(3y)1.29%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DHAI Yearly ROA, ROE, ROICDHAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 2 -2

1.3 Margins

DHAI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DHAI Yearly Profit, Operating, Gross MarginsDHAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, DHAI has about the same amount of shares outstanding.
There is no outstanding debt for DHAI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DHAI Yearly Shares OutstandingDHAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
DHAI Yearly Total Debt VS Total AssetsDHAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of 0.74, we must say that DHAI is in the distress zone and has some risk of bankruptcy.
DHAI has a Altman-Z score (0.74) which is comparable to the rest of the industry.
DHAI has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
DHAI has a better Debt to Equity ratio (0.03) than 63.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 0.74
ROIC/WACCN/A
WACCN/A
DHAI Yearly LT Debt VS Equity VS FCFDHAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

DHAI has a Current Ratio of 0.02. This is a bad value and indicates that DHAI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.02, DHAI is doing worse than 98.40% of the companies in the same industry.
DHAI has a Quick Ratio of 0.02. This is a bad value and indicates that DHAI is not financially healthy enough and could expect problems in meeting its short term obligations.
DHAI's Quick ratio of 0.02 is on the low side compared to the rest of the industry. DHAI is outperformed by 98.40% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
DHAI Yearly Current Assets VS Current LiabilitesDHAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 100K 200K 300K 400K

More info and screens

0

3. Growth

3.1 Past

DHAI shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.13%.
EPS 1Y (TTM)-1.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DHAI Yearly Revenue VS EstimatesDHAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023
DHAI Yearly EPS VS EstimatesDHAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.33, the valuation of DHAI can be described as very cheap.
Based on the Price/Earnings ratio, DHAI is valued cheaply inside the industry as 98.94% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of DHAI to the average of the S&P500 Index (28.20), we can say DHAI is valued rather cheaply.
Industry RankSector Rank
PE 7.33
Fwd PE N/A
DHAI Price Earnings VS Forward Price EarningsDHAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DHAI Per share dataDHAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DHAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DIH HOLDINGS US INC

NASDAQ:DHAI (2/11/2025, 11:18:13 AM)

0.66

-0.03 (-4.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.69%
Inst Owner Change-41.09%
Ins OwnersN/A
Ins Owner Change100%
Market Cap22.80M
AnalystsN/A
Price TargetN/A
Short Float %1.44%
Short Ratio0.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.33
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.49
EV/EBITDA N/A
EPS(TTM)0.09
EY13.64%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS1.34
TBVpS1.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.45%
ROE 1.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.29%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 0.74
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)102.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%400%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.36%
OCF growth 3YN/A
OCF growth 5YN/A